Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Accumulated Expenses (2020 - 2025)

iHuman has reported Accumulated Expenses over the past 6 years, most recently at $16.3 million for Q4 2025.

  • Quarterly Accumulated Expenses rose 63.89% to $16.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.3 million through Dec 2025, up 63.89% year-over-year, with the annual reading at $8.0 million for FY2025, 91.85% up from the prior year.
  • Accumulated Expenses was $16.3 million for Q4 2025 at iHuman, up from $10.0 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $20.3 million in Q4 2022 and troughed at $2.7 million in Q4 2021.
  • The 5-year median for Accumulated Expenses is $10.0 million (2024), against an average of $10.7 million.
  • Biggest five-year swings in Accumulated Expenses: surged 653.68% in 2022 and later crashed 80.39% in 2023.
  • Tracing IH's Accumulated Expenses over 5 years: stood at $2.7 million in 2021, then soared by 653.68% to $20.3 million in 2022, then crashed by 80.39% to $4.0 million in 2023, then surged by 149.54% to $10.0 million in 2024, then soared by 63.89% to $16.3 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $16.3 million, $10.0 million, and $4.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.